EUROVISCO; clinical scenario; hyaluronic acid; knee; osteoarthritis; recommendations; viscosupplementation; Immunology and Allergy; Biomedical Engineering; Physical Therapy, Sports Therapy and Rehabilitation
Abstract :
[en] [en] OBJECTIVE: Viscosupplementation (VS) by intra-articular injections of hyaluronic acid (HA) is a commonly used treatment of knee osteoarthritis. However, there are no clear recommendations for its use in clinical situations not usually addressed in therapeutic guidelines.
DESIGN: Members of the European Viscosupplementation Consensus Group (EUROVISCO), made up of rheumatologists, orthopedic surgeons, and rehabilitation physicians from seven European countries, were asked to make a therapeutic decision on 30 clinical scenarios based on their clinical experience and data from the literature, using the Delphi method. For each scenario, the strength of agreement and the level of consensus were calculated by the chairman of the group.
RESULTS: The expert panel reached consensus on 18 of the 30 clinical scenarios proposed. According to the experts, the factors that most influence the decision to use VS with HA to treat knee osteoarthritis are the nature and severity of symptoms, the presence of comorbidity, the absence of therapeutic alternatives, and the patient's refusal to undergo knee arthroplasty. Obesity and an advanced radiological degree of osteoarthritis have been identified as the two main factors for poor response to VS with HA and should be considered before any decision is made to viscosupplement.
CONCLUSION: This set of recommendations, based on common clinical scenarios, is intended to help practitioners make decisions about HA VS in patients with osteoarthritis of the knee.
Disciplines :
Rheumatology
Author, co-author :
Monfort, Jordi; Servei de Reumatologia, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain
Henrotin, Yves ; Université de Liège - ULiège > Département des Sciences de l'activité physique et de la réadaptation > Pathologie générale et physiopathologie - Techniques particulières de kinésithérapie ; Physical Therapy and Rehabilitation Department, Princess Paola Hospital, Vivalia, Marche-en-famenne, Belgium
Chevalier, Xavier; Paris XII University, UPEC, Department of Rheumatology, Henri Mondor Hospital, Creteil, France
Migliore, Alberto; U.O.S. of Rheumatology, Ospedale San Pietro Fatebenefratelli, Rome, Italy
Baron, Dominique; Centre de réadaptation fonctionnelle de Lannion-Trestel, Trévou-Tréguignec, France
Richette, Pascal; Université Paris Diderot, UFR médicale, Hôpital Lariboisière, Paris, France
Bard, Hervé; Rheumatology Cabinet medical Vaudoyer, Paris, France
Brittberg, Mats ; Cartilage Research Unit, University of Gothenburg, Department of Orthopaedics, Varberg Hospital and Team Orthopaedic Research Region Halland (TOR), Varberg, Sweden
Diraçoglù, Demirhan; Department of Physical Medicine and Rehabilitation, Istanbul University and Istanbul Faculty of medicine, Istanbul, Turkiye
Raman, Raghu; Department of Orthopaedics, Academic Unit of Orthopaedics and Rheumatology, CMMH Hospital, Chennai, India
Conrozier, Thierry ; Department of Rheumatology, Hôpital Nord Franche-Comté, Belfort, France
Language :
English
Title :
EUROVISCO Good Medical Practice Recommendations for the Use of Viscosupplementation with Hyaluronic Acid in the Management of Knee Osteoarthritis.
Hunter DJ Bierma-Zeinstra S. Osteoarthritis. Lancet. 2019;393(10182):1745-59. doi: 10.1016/S0140-6736(19)30417-9
Puig-Junoy J Ruiz Zamora A. Socio-economic costs of osteoarthritis: a systematic review of cost-of-illness studies. Semin Arthritis Rheum. 2015;44(5):531-41. doi: 10.1016/j.semarthrit.2014.10.012
Zhao X Shah D Gandhi K Wei W Dwibedi N Webster L, et al. Clinical, humanistic, and economic burden of osteoarthritis among noninstitutionalized adults in the United States. Osteoarthritis Cartilage. 2019;27(11):1618-26. doi: 10.1016/j.joca.2019.07.002
Overton C Nelson AE Neogi T. Osteoarthritis treatment guidelines from six professional societies: similarities and differences. Rheum Dis Clin North Am. 2022;48(3):637-57. doi: 10.1016/j.rdc.2022.03.009
Sellam J Courties A Eymard F Ferrero S Latourte A Ornetti P, et al. Recommendations of the French society of rheumatology on pharmacological treatment of knee osteoarthritis. Joint Bone Spine. 2020;87(6):548-55. doi: 10.1016/j.jbspin.2020.09.004
Monfort J Carné X Abarca B, et al. Experts document about an adequate utilization of SYSADOAs in controversial clinical situations. Reumatol Clin (Engl Ed). 2021;17(10):595-600. doi: 10.1016/j.reumae.2020.06.009
Ayhan E Kesmezacar H Akgun I. Intraarticular injections (corticosteroid, hyaluronic acid, platelet rich plasma) for the knee osteoarthritis. World J Orthop. 2014;5(3):351-61. doi: 10.5312/wjo.v5.i3.351
Wang F He X. Intra-articular hyaluronic acid and corticosteroids in the treatment of knee osteoarthritis: a meta-analysis. Exp Ther Med. 2015;9(2):493-500. doi: 10.3892/etm.2014.2131
Bhadra AK Altman R Dasa V Myrick K Rosen J Vad V, et al. Appropriate use criteria for hyaluronic acid in the treatment of knee osteoarthritis in the United States. Cartilage. 2017;8(3):234-54. doi: 10.1177/1947603516662503
Bellamy N Hochberg M Tubach F Martin-Mola E Awada H Bombardier C, et al. Development of multinational definitions of minimal clinically important improvement and patient acceptable symptomatic state in osteoarthritis. Arthritis Care Res (Hoboken). 2015;67(7):972-80. doi: 10.1002/acr.22538
Bannuru RR Vaysbrot EE Sullivan MC McAlindon TE. Relative efficacy of hyaluronic acid in comparison with NSAIDs for knee osteoarthritis: a systematic review and meta-analysis. Semin Arthritis Rheum. 2014;43(5):593-9. doi: 10.1016/j.semarthrit.2013.10.002
Arden NK Perry TA Bannuru RR Bruyère O Cooper C Haugen IK, et al. Non-surgical management of knee osteoarthritis: comparison of ESCEO and OARSI 2019 guidelines. Nat Rev Rheumatol. 2021;17(1):59-66. doi: 10.1038/s41584-020-00523-9
Kolasinski SL Neogi T Hochberg MC, et al. 2019 American College of Rheumatology/Arthritis foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Rheumatol. 2020;72(2):220-33. doi: 10.1002/art.41142
Uson J Rodriguez-García SC Castellanos-Moreira R O’Neill TW Doherty M Boesen M, et al. EULAR recommendations for intra-articular therapies. Ann Rheum Dis. 2021;80(10):1299-305. doi: 10.1136/annrheumdis-2021-220266
Bannuru RR Osani M Vaysbrot EE McAlindon TE. Comparative safety profile of hyaluronic acid products for knee osteoarthritis: a systematic review and network meta-analysis. Osteoarthritis Cartilage. 2016;24(12):2022-41. doi: 10.1016/j.joca.2016.07.010
Eymard F Chevalier X Conrozier T. Obesity and radiological severity are associated with viscosupplementation failure in patients with knee osteoarthritis. J Orthop Res. 2017;35(10):2269-74. doi: 10.1002/jor.23529
Conrozier T Diraçoglù D Monfort J Chevalier X Bard H Baron D, et al. EUROVISCO good practice recommendations for a first viscosupplementation in patients with knee osteoarthritis. Cartilage. 2023;14(2):125-35. doi: 10.1177/19476035221138958
Nicholls M Shaw P Niazi F Bhandari M Bedi A. The impact of excluding patients with end-stage knee disease in intra-articular hyaluronic acid trials: a systematic review and meta-analysis. Adv Ther. 2019;36(1):147-61. doi: 10.1007/s12325-018-0847-1
Conrozier T. How to treat osteoarthritis in obese patients? Curr Rheumatol Rev. 2020;16(2):99-104. doi: 10.2174/1573397115666190625105759
Conrozier T Eymard F Chouk M Chevalier X. Impact of obesity, structural severity and their combination on the efficacy of viscosupplementation in patients with knee osteoarthritis. BMC Musculoskelet Disord. 2019;1720(1):376. doi: 10.1186/s12891-019-2748-0
Trojian TH Concoff AL Joy SM Hatzenbuehler JR Saulsberry WJ Coleman CI. AMSSM scientific statement concerning viscosupplementation injections for knee osteoarthritis: importance for individual patient outcomes. Br J Sports Med. 2016;50(2):84-92. doi: 10.1136/bjsports-2015-095683
Berlinberg EJ Song M Sivasundaram L Patel HH Mascarenhas R Forsythe B. Total knee arthroplasty after meniscectomy is more likely in patients with bicompartmental or complex tears. Arthrosc Sports Med Rehabil. 2023;5(3):e577-e587. doi: 10.1016/j.asmr.2023.02.010
